28-joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: The Swedish TIRA project

Rheumatology

Volumn 50, Issue 7, 2011, Pages 1259-1267

  Hallert, Eva ^a,b   Husberg, Magnus ^a   Skogh, Thomas ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Direct costs; Disease activity score 28; Early rheumatoid arthritis; EuroQol 5D; Indirect costs; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH VISITOR; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SWEDEN;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COST OF ILLNESS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME FACTORS;

EID: 79959397951     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq444     Document Type: Article

References (29)

1. Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis. An updated systematic review. Clin Exp Rheum 2003;21:S20-7.
2. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. German Collaborative Arthritis Centres. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006;65:1175-83.
3. Kavanaugh A. Economic consequences of established rheumatoid arthritis and its treatment. Best Pract Res Clin Rheumatol 2007;21:929-42.
4. Newhall-Perry K, Law NJ, Ramos B et al. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. J Rheumatol 2000;27: 156-63.
5. Hallert E, Husberg M, Jonsson D, Skogh T. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA Project). heumatology 2004; 43:1374-82.
6. van Jaarsveld CHM, Jacobs JWG, Schrijvers AJP, Heurkens AHM, Haanen HCM, Bijlsma JWJ. Direct cost of rheumatoid arthritis during the first six ears: a cost-of-illness study. Br J Rheumatol 1998;37: 837-49.
7. Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 atients. Arthritis Rheum 2003;48:2750-62.
8. Kavanaugh A, Han C, Bala M. Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid rthritis. J Rheumatol 2004;31:849-55.
9. Puolakka K, Kautiainen H, Mottonen T et al. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis. Scand J Rheumatol 2009;38:96-103.
10. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42: 1854-60.
11. Sokka T, Kankainen A, Hannonen P. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis Rheum 2000;43: 386-9.
12. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44: 2009-17.
13. Aletaha D, Funovits J, Keystone EC, Smolen JS. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid rthritis patients. Arthritis Rheum 2007;56:3226-35.
14. Guillemin F, Durieux S, Daure's JP et al. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based heumatologists. J Rheumatol 2004;31:1297-304.
15. Macedo A, Oakley S, Gullick N, Kirkham B. An examination of work instability, functional impairment, and disease activity in employed patients with heumatoid arthritis. J Rheumatol 2009;36:225-30.
16. Hallert E, Husberg M, Skogh T. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project). heumatology 2006; 45:325-31.
17. Hallert E, Thyberg I, Hass U, Skargren E, Skogh T. Comparison between women and men with recent-onset rheumatoid arthritis regarding disease activity and functional ability over two years (the TIRA project). Ann Rheum Dis 2003;62:667-70.
18. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. rthritis Rheum 1988; 31:315-24.
19. Preevo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified disease activity scores that include twenty-ight-joint counts. Arthritis Rheum 1995;38:44-8.
20. Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988;17: 263-71.
21. The EuroQol group. The EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
22. Federation of Swedish County Councils (Landstingsförbundet). Stockholm; 2001. www.lf.se (16 January 2011, date last accessed).
23. Serden L, Lindquist R, Rosen M. Have DRG-based prospective payment systems influenced the number of secondary diagnoses in health care dministrative data? Health Policy 2003;65:101-17.
24. Statistics. Sweden; 2001. www.scb.se (16 January 2011, date last accessed).
25. van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK et al. Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Ann Rheum Dis 2008;67:266-9.
26. Verschueren P, Esselens G, Westhovens R. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Scand J Rheumatol 2009;38:166-72.
27. Puolakka K, Kautiainen H, Pekurinen M et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 2006;65:899-904.
28. Verstappen SM, Boonen A, Verkleij H, Bijlsma JW, Buskens E, Jacobs JW. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis 2005;64:1754-60.
29. Rouf J, Huelsemann JL, Mittendorf T et al. Patientreported health care utilization in rheumatoid arthritis: what level of detail is required? Arthritis Care Res 004;51: 774-81.